- Home
- SMID vs ACHV Comparison
SMID vs ACHV Comparison
Compare SMID & ACHV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SMID
- ACHV
- Stock Information
- Founded
- SMID 1960
- ACHV N/A
- Country
- SMID United States
- ACHV Canada
- Employees
- SMID N/A
- ACHV N/A
- Industry
- SMID Building Materials
- ACHV Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- SMID Industrials
- ACHV Health Care
- Exchange
- SMID Nasdaq
- ACHV Nasdaq
- Market Cap
- SMID 166.5M
- ACHV 126.9M
- IPO Year
- SMID 1995
- ACHV N/A
- Fundamental
- Price
- SMID $39.43
- ACHV $3.15
- Analyst Decision
- SMID
- ACHV Strong Buy
- Analyst Count
- SMID 0
- ACHV 5
- Target Price
- SMID N/A
- ACHV $14.80
- AVG Volume (30 Days)
- SMID 22.1K
- ACHV 260.4K
- Earning Date
- SMID 11-14-2024
- ACHV 11-07-2024
- Dividend Yield
- SMID N/A
- ACHV N/A
- EPS Growth
- SMID 1025.92
- ACHV N/A
- EPS
- SMID 1.22
- ACHV N/A
- Revenue
- SMID $76,366,000.00
- ACHV N/A
- Revenue This Year
- SMID N/A
- ACHV N/A
- Revenue Next Year
- SMID N/A
- ACHV N/A
- P/E Ratio
- SMID $31.93
- ACHV N/A
- Revenue Growth
- SMID 32.40
- ACHV N/A
- 52 Week Low
- SMID $25.03
- ACHV $3.12
- 52 Week High
- SMID $51.96
- ACHV $5.59
- Technical
- Relative Strength Index (RSI)
- SMID 37.98
- ACHV 26.85
- Support Level
- SMID $37.70
- ACHV $3.50
- Resistance Level
- SMID $40.20
- ACHV $3.86
- Average True Range (ATR)
- SMID 2.17
- ACHV 0.20
- MACD
- SMID -0.81
- ACHV -0.03
- Stochastic Oscillator
- SMID 17.40
- ACHV 4.05
About SMID Smith-Midland Corporation
Smith-Midland Corp through its subsidiaries invents, develops, manufactures, markets, sells, and installs precast concrete products for primary use in the construction, highway, utilities, and farming industries. The firm's customers are general contractors and federal, state, and local transportation authorities. Its products include Slenderwall, JJhooks, Softsound, Sierra Wall and Easi set. A substantial portion of the company's business is derived from local, state, and federal building projects. The company generates revenues predominantly from the sale, leasing, licensing, shipping, and installation of precast concrete products for the construction, utility, and farming industries.
About ACHV Achieve Life Sciences Inc.
Achieve Life Sciences Inc is a specialty pharmaceutical company committed to advancing cytisinicline as a widely available treatment option to help people battling nicotine addiction. It is an established smoking cessation treatment that has been approved and marketed in Central and Eastern Europe. Achieve's focus is to address the smoking health epidemic through the development and commercialization of cytisinicline. It has one operating segment, dedicated to the development and commercialization of cytisinicline for niceon.